The estimated Net Worth of Roland Boyd is at least $34.8 mil dollars as of 19 August 2019. Roland Boyd owns over 61,100 units of Quotient Ltd stock worth over $34,811 and over the last 9 years Roland sold QTNT stock worth over $0.
Sign up
Roland Boyd QTNT stock SEC Form 4 insiders trading
Roland has made over 1 trades of the Quotient Ltd stock since 2019, according to the Form 4 filled with the SEC. Most recently Roland exercised 61,100 units of QTNT stock worth $194,909 on 19 August 2019.
The largest trade Roland's ever made was exercising 61,100 units of Quotient Ltd stock on 19 August 2019 worth over $194,909. On average, Roland trades about 7,638 units every 0 days since 2015. As of 19 August 2019 Roland still owns at least 91,608 units of Quotient Ltd stock.
You can see the complete history of Roland Boyd stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Roland Boyd's mailing address?
Roland's mailing address filed with the SEC is C/O QUOTIENT LIMITED, 28 ESPLANADE, ST HELIER, Y9, JE2 3QA.
Insiders trading at Quotient Ltd
Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff, eL John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.
What does Quotient Ltd's logo look like?
Complete history of Roland Boyd stock trades at Quotient Ltd
Quotient Ltd executives and stock owners
Quotient Ltd executives and other stock owners filed with the SEC include:
-
Franz Walt,
Chief Executive Officer, Director -
Edward Farrell,
Chief Operating Officer -
Jeremy Stackawitz,
Chief Commercial Officer -
Peter Buhler,
Chief Financial Officer -
Heino.N.F.M von Prondzynski,
Independent Chairman of the Board -
Frederick Hallsworth,
Independent Director -
Brian McDonough,
Independent Director -
Zubeen Shroff,
Independent Director -
John Wilkerson,
Independent Director -
Catherine Larue,
Independent Director -
Isabelle Buckle,
Independent Director -
Ernest Larnach,
Head - Financial Accounting & Treasury -
Esteban Uriarte,
Chief Manufacturing Operations Officer -
Mohammad El Khoury,
Chief Commercial Officer -
Christian Albrich,
Chief People Officer -
Dr. Christine Ginocchio,
Chief Scientific & Medical Officer -
Dr. Michael Hausmann,
Chief Technology Officer -
Vittoria Bonasso,
Head of Fin., Group Controller & Principal Accounting Officer -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
CEO & Director -
Ernest Larnach,
Head of Financial Accounting & Treasury -
Vittoria Bonasso,
See Remarks -
Roland Boyd,
See Remarks -
Thomas A Bologna,
Director -
Sarah A Oconnor,
Director -
Stephen Unger,
Chief Financial Officer -
Partners V Lp Galen Partner...,
-
Deidre Quotient Biodiagnost...,
-
D J Paul E Cowan,
See Remarks -
Sophie Bechu,
Director -
Advisors Llcperceptive Life...,
-
Christopher J Lindop,
EVP -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
Chief Executive Officer -
Khoury Mohammad El,
Chief Commercial Officer -
Thomas Aebischer,
Director